BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-05-28 |
|---|---|---|---|---|
| 2026 | $71.2 | $54.32 | $92.58 | 35.01% |
| 2027 | $129.19 | $101.06 | $145.24 | 144.97% |
| 2028 | $160.03 | $147.42 | $171.99 | 203.43% |
| 2029 | $177.12 | $173.02 | $181.52 | 235.83% |
| 2030 | $174.08 | $166.96 | $182.32 | 230.08% |
| 2031 | $145.18 | $130.28 | $165.73 | 175.27% |
| 2032 | $120.85 | $116.64 | $128.74 | 129.14% |
| 2033 | $112.87 | $109.21 | $115.78 | 114.01% |
| 2034 | $100.92 | $94.7 | $107.94 | 91.35% |
| 2035 | $98.89 | $96.52 | $101.41 | 87.5% |
| 2036 | $96.83 | $96.51 | $97.32 | 83.59% |
The 23 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$86.26 with a high forecast of $120.0 and a low forecast of $50.0.
The average BioMarin Pharmaceutical stock forecast represents a 63.56%
increase from the last price of $52.7400016784668.
For BioMarin Pharmaceutical stock forecast for 2026, 7 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $71.2, a high forecast of $92.58, and a low forecast of $54.32.
The average BioMarin Pharmaceutical stock forecast 2026 represents a 35.01%
increase from the last price of $52.7400016784668.
For BioMarin Pharmaceutical stock forecast for 2027, 12 predictions are offered for each month of 2027 with average BioMarin Pharmaceutical stock
forecast of $129.19, a high forecast of $145.24, and a low forecast of $101.06.
The average BioMarin Pharmaceutical stock forecast 2027 represents a 144.97%
increase from the last price of $52.7400016784668.
For BioMarin Pharmaceutical stock forecast for 2029, 12 predictions are offered for each month of 2029 with average BioMarin Pharmaceutical stock
forecast of $177.12, a high forecast of $181.52, and a low forecast of $173.02.
The average BioMarin Pharmaceutical stock forecast 2029 represents a 235.83%
increase from the last price of $52.7400016784668.
For BioMarin Pharmaceutical stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $145.18, a high forecast of $165.73, and a low forecast of $130.28.
The average BioMarin Pharmaceutical stock forecast 2031 represents a 175.27%
increase from the last price of $52.7400016784668.
For BioMarin Pharmaceutical stock forecast 2032, 12 predictions are offered for each month of 2032 with average BioMarin Pharmaceutical stock
forecast of $120.85, a high forecast of $128.74, and a low forecast of $116.64.
The average BioMarin Pharmaceutical stock forecast 2032 represents a 129.14%
increase from the last price of $52.7400016784668.
For BioMarin Pharmaceutical stock forecast for 2036 (10 year), 5 predictions are offered for each month of 2036 with average BioMarin Pharmaceutical stock
forecast of $96.83, a high forecast of $97.32, and a low forecast of $96.51.
The average BioMarin Pharmaceutical stock forecast 2036 represents a 83.59%
increase from the last price of $52.7400016784668.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $86.26, and this show a -1.34% decrease in average from the prior price target of the each prediction. Also, this average forecast of $86.26 represents a 3.27% increase from the past average forecast of $83.53, 6 months ago from 17 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2026-05-22 | Canaccord Genuity | $116.00 | $111.0000 | Buy |
| 2026-05-19 | Citigroup | $75.0000 | Buy | |
| 2026-05-19 | B of A Securities | $85.00 | $80.0000 | Buy |
| 2026-05-18 | HC Wainwright & Co. | $55.0000 | $50.0000 | Neutral |
| 2026-05-11 | Goldman Sachs | $69.0000 | Neutral | |
| 2026-05-07 | Canaccord Genuity | $104.00 | $116.0000 | Buy |
| 2026-05-05 | RBC Capital | $66.0000 | $66.0000 | Sector Perform |
| 2026-05-05 | Bernstein | $94.00 | $82.0000 | Outperform |
| 2026-05-05 | Morgan Stanley | $120.0000 | $119.0000 | Overweight |
| 2026-05-05 | Evercore ISI Group | $110.0000 | $120.0000 | Outperform |
| 2026-05-05 | HC Wainwright & Co. | $55.00 | $55.0000 | Neutral |
| 2026-03-11 | B of A Securities | $97.0000 | $85.0000 | Buy |
| 2026-03-04 | Barclays | $80.00 | $105.0000 | Overweight |
| 2026-03-02 | Freedom Broker | $100.00 | $105.0000 | Buy |
| 2026-03-02 | HC Wainwright & Co. | $55.00 | $55.0000 | Neutral |
| 2026-02-26 | Canaccord Genuity | $98.00 | $104.0000 | Buy |
| 2026-02-25 | Guggenheim | $106.0000 | $86.0000 | Buy |
| 2026-02-25 | Bernstein | $90.0000 | $94.0000 | Outperform |
| 2026-02-25 | HC Wainwright & Co. | $60.0000 | $55.0000 | Neutral |
| 2026-02-24 | Oppenheimer | $98.00 | $95 | Outperform |
| 2026-02-18 | Wells Fargo | $70.00 | $75.0000 | Overweight |
| 2026-02-06 | Piper Sandler | $122.0000 | $84.0000 | Overweight |
| 2026-01-20 | Canaccord Genuity | $84.00 | $98.0000 | Buy |
| 2025-12-23 | Truist Securities | $80.00 | $100 | Buy |
| 2025-12-22 | HC Wainwright & Co. | $55.0000 | $60.0000 | Neutral |
| 2025-12-03 | Leerink Partners | $82.0000 | $60.0000 | Market Perform |
| 2025-11-06 | Stifel | $73.00 | $61.0000 | Hold |
| 2025-11-03 | Freedom Broker | $125.0000 | $100.0000 | Buy |
| 2025-11-03 | Bernstein | $95.0000 | $88.0000 | Outperform |
| 2025-10-28 | Morgan Stanley | $104.0000 | $98.0000 | Overweight |
| 2025-10-28 | Barclays | $86.00 | $80.0000 | Overweight |
| 2025-10-28 | Stifel | $91.0000 | $73.0000 | Buy |
| 2025-10-28 | Wells Fargo | $90.00 | $70.0000 | Overweight |
| 2025-10-28 | Truist Securities | $90.00 | $80.0000 | Buy |
| 2025-10-27 | HC Wainwright & Co. | $60.00 | $55.0000 | Neutral |
| 2025-10-09 | JP Morgan | $116.0000 | $119.0000 | Overweight |
| 2025-09-08 | HC Wainwright & Co. | $60 | Neutral | |
| 2025-08-06 | Guggenheim | $101.0000 | $106.0000 | Buy |
| 2025-08-05 | UBS | $113.00 | $114.0000 | Buy |
| 2025-07-22 | Morgan Stanley | $97.0000 | $96.0000 | Overweight |
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-05-29 | $53.84 | 2.09% |
| 2026-06-01 | $55.60 | 3.27% |
| 2026-06-02 | $58.96 | 6.05% |
| 2026-06-03 | $61.55 | 4.39% |
| 2026-06-04 | $62.31 | 1.23% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Jun. is $54.32 , for 2027 May. is $128.18 , for 2030 May. is $175.88 , for 2031 May. is $150.93 , for 2035 May. is $99.83 , and for 2036 May. is $97.32.
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jun. | $54.32 | 2.99% |
| 2026 Jul. | $57.96 | 6.71% |
| 2026 Aug. | $63.23 | 9.08% |
| 2026 Sep. | $69.41 | 9.77% |
| 2026 Oct. | $76.52 | 10.24% |
| 2026 Nov. | $84.42 | 10.33% |
| 2026 Dec. | $92.58 | 9.67% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $101.06 | 9.16% |
| 2027 Feb. | $109.17 | 8.03% |
| 2027 Mar. | $116.66 | 6.86% |
| 2027 Apr. | $123.01 | 5.44% |
| 2027 May. | $128.18 | 4.20% |
| 2027 Jun. | $131.82 | 2.84% |
| 2027 Jul. | $134.70 | 2.18% |
| 2027 Aug. | $137.07 | 1.76% |
| 2027 Sep. | $139.16 | 1.53% |
| 2027 Oct. | $141.14 | 1.43% |
| 2027 Nov. | $143.15 | 1.42% |
| 2027 Dec. | $145.24 | 1.46% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $147.42 | 1.51% |
| 2028 Feb. | $149.65 | 1.51% |
| 2028 Mar. | $151.84 | 1.46% |
| 2028 Apr. | $153.97 | 1.40% |
| 2028 May. | $156.09 | 1.38% |
| 2028 Jun. | $158.41 | 1.49% |
| 2028 Jul. | $161.08 | 1.69% |
| 2028 Aug. | $163.95 | 1.78% |
| 2028 Sep. | $166.57 | 1.60% |
| 2028 Oct. | $168.79 | 1.33% |
| 2028 Nov. | $170.58 | 1.06% |
| 2028 Dec. | $171.99 | 0.82% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $173.02 | 0.60% |
| 2029 Feb. | $173.87 | 0.49% |
| 2029 Mar. | $174.54 | 0.38% |
| 2029 Apr. | $174.90 | 0.21% |
| 2029 May. | $174.95 | 0.03% |
| 2029 Jun. | $175.29 | 0.19% |
| 2029 Jul. | $176.38 | 0.62% |
| 2029 Aug. | $178.35 | 1.11% |
| 2029 Sep. | $180.22 | 1.05% |
| 2029 Oct. | $181.03 | 0.45% |
| 2029 Nov. | $181.31 | 0.15% |
| 2029 Dec. | $181.52 | 0.12% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $181.84 | 0.18% |
| 2030 Feb. | $182.32 | 0.26% |
| 2030 Mar. | $180.43 | -1.04% |
| 2030 Apr. | $177.41 | -1.67% |
| 2030 May. | $175.88 | -0.86% |
| 2030 Jun. | $174.39 | -0.85% |
| 2030 Jul. | $172.75 | -0.94% |
| 2030 Aug. | $171.09 | -0.97% |
| 2030 Sep. | $169.64 | -0.84% |
| 2030 Oct. | $168.55 | -0.64% |
| 2030 Nov. | $167.73 | -0.49% |
| 2030 Dec. | $166.96 | -0.45% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $165.73 | -0.74% |
| 2031 Feb. | $163.13 | -1.57% |
| 2031 Mar. | $159.19 | -2.41% |
| 2031 Apr. | $155.11 | -2.56% |
| 2031 May. | $150.93 | -2.69% |
| 2031 Jun. | $145.21 | -3.79% |
| 2031 Jul. | $139.15 | -4.17% |
| 2031 Aug. | $135.56 | -2.58% |
| 2031 Sep. | $133.74 | -1.34% |
| 2031 Oct. | $132.59 | -0.86% |
| 2031 Nov. | $131.50 | -0.82% |
| 2031 Dec. | $130.28 | -0.93% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $128.74 | -1.18% |
| 2032 Feb. | $126.58 | -1.68% |
| 2032 Mar. | $123.64 | -2.33% |
| 2032 Apr. | $121.05 | -2.09% |
| 2032 May. | $119.89 | -0.96% |
| 2032 Jun. | $119.69 | -0.16% |
| 2032 Jul. | $119.68 | -0.01% |
| 2032 Aug. | $119.47 | -0.18% |
| 2032 Sep. | $118.99 | -0.40% |
| 2032 Oct. | $118.31 | -0.57% |
| 2032 Nov. | $117.51 | -0.68% |
| 2032 Dec. | $116.64 | -0.74% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $115.78 | -0.74% |
| 2033 Feb. | $115.04 | -0.64% |
| 2033 Mar. | $114.48 | -0.49% |
| 2033 Apr. | $114.05 | -0.37% |
| 2033 May. | $113.69 | -0.31% |
| 2033 Jun. | $113.34 | -0.31% |
| 2033 Jul. | $112.95 | -0.35% |
| 2033 Aug. | $112.48 | -0.42% |
| 2033 Sep. | $111.91 | -0.51% |
| 2033 Oct. | $111.20 | -0.63% |
| 2033 Nov. | $110.32 | -0.80% |
| 2033 Dec. | $109.21 | -1.01% |
BMRN : BioMarin Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $107.94 | -1.16% |
| 2034 Feb. | $106.61 | -1.23% |
| 2034 Mar. | $105.27 | -1.25% |
| 2034 Apr. | $103.28 | -1.89% |
| 2034 May. | $98.85 | -4.29% |
| 2034 Jun. | $95.20 | -3.69% |
| 2034 Jul. | $94.70 | -0.52% |
| 2034 Aug. | $96.60 | 2.00% |
| 2034 Sep. | $99.79 | 3.30% |
| 2034 Oct. | $101.38 | 1.59% |
| 2034 Nov. | $100.83 | -0.53% |
| 2034 Dec. | $100.57 | -0.26% |
BMRN : BioMarin Pharmaceutical stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $101.02 | 0.45% |
| 2035 Feb. | $101.41 | 0.38% |
| 2035 Mar. | $101.23 | -0.17% |
| 2035 Apr. | $100.59 | -0.64% |
| 2035 May. | $99.83 | -0.75% |
| 2035 Jun. | $99.10 | -0.73% |
| 2035 Jul. | $98.41 | -0.69% |
| 2035 Aug. | $97.79 | -0.63% |
| 2035 Sep. | $97.27 | -0.53% |
| 2035 Oct. | $96.88 | -0.40% |
| 2035 Nov. | $96.63 | -0.25% |
| 2035 Dec. | $96.52 | -0.12% |
BMRN : BioMarin Pharmaceutical stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $96.51 | -0.00% |
| 2036 Feb. | $96.59 | 0.08% |
| 2036 Mar. | $96.74 | 0.16% |
| 2036 Apr. | $96.97 | 0.24% |
| 2036 May. | $97.32 | 0.36% |
Financial Data for BioMarin Pharmaceutical stock
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2026 Jun. is $54.3190528758454 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2027 May. is $128.175019462583 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2030 May. is $175.877261420317 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2031 May. is $150.933185525384 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2035 May. is $99.8302524805181 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2036 May. is $97.3204678825039
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go UP . Therefore, AIPickup would say that BioMarin Pharmaceutical (BMRN) stock is NOT overvalued.
Will BioMarin Pharmaceutical stock price go up?
Yes. The BioMarin Pharmaceutical stock price forecast for 2027 May. is $128.175019462583
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2026-05-28 is $52.7400016784668 and forecast for 2027 May. is $128.18, BioMarin Pharmaceutical stock is a good 1 year investment.
14 Days Historical Data for BioMarin Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BMRN stock price for 2026-05-08 | $54.06 | $54.15 | $53.53 | $54.55 |
| BMRN stock price for 2026-05-11 | $52.58 | $53.46 | $52.48 | $54.50 |
| BMRN stock price for 2026-05-12 | $52.88 | $52.93 | $52.36 | $53.15 |
| BMRN stock price for 2026-05-13 | $53.55 | $52.50 | $52.08 | $53.70 |
| BMRN stock price for 2026-05-14 | $53.24 | $53.78 | $52.64 | $54.09 |
| BMRN stock price for 2026-05-15 | $51.81 | $53.41 | $51.68 | $53.41 |
| BMRN stock price for 2026-05-18 | $49.67 | $51.61 | $49.26 | $52.25 |
| BMRN stock price for 2026-05-19 | $49.81 | $50.25 | $49.48 | $50.95 |
| BMRN stock price for 2026-05-20 | $50.20 | $49.81 | $49.41 | $50.45 |
| BMRN stock price for 2026-05-21 | $54.10 | $52.22 | $52.13 | $54.45 |
| BMRN stock price for 2026-05-22 | $54.09 | $54.04 | $53.56 | $55.05 |
| BMRN stock price for 2026-05-26 | $52.88 | $54.20 | $52.76 | $54.48 |
| BMRN stock price for 2026-05-27 | $52.38 | $52.78 | $52.20 | $53.31 |
| BMRN stock price for 2026-05-28 | $52.74 | $52.40 | $52.20 | $53.00 |